PCR @ TCT 2024 - Get the international perspective!

Everything you need to know about #TCT2024 - condensed take-home messages covering major late-breaking clinical trials, registries and studies

TCT 2024 - October 27-30, 2024

Mirvat Alasnag, Elad Asher, Luigi Biasco, Aaysha Cader, Ali Nazmi Calik, Daniele Giacoppo, Dejan Milasinovic, Nicola Ryan, Alex Sticchi and Panos Xaplanteris will review a selection of major Late-breaking Clinical Trials and Science (LBTs) in Interventional Cardiology released at the 2024 Transcatheter Cardiovascular Therapeutics Congress (TCT 2024).

Late-breaking Clinical Trials and Science covered:

• Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial
• Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
• Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis (TAVR UNLOAD) - An interview with Nicolas M. Van Mieghem
• Comparison of noncompliant balloon with drug-coating balloon angioplasties for side branch after provisional stenting for patients with true coronary bifurcation lesions: The prospective, multicenter, randomized DCB-BIF Trial
• Comparison of puncture success rate between distal radial access and transradial access in patients with ST-elevation myocardial infarction (DRAMI)
• A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)
• Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism: primary outcomes from the PEERLESS randomized controlled trial
• Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: the SIRONA randomized controlled trial
• TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation - An interview with Susheel K. Kodali
• Quantitative flow ratio or fractional flow reserve for guiding coronary revascularization (FAVOR III Europe)
• Artificial intelligence-based fully automated quantitative coronary angiography versus optical coherence tomography guidance for coronary stent implantation: a multicenter, randomized controlled non-inferiority trial (FLASH)

CRF & PCR Partners in Learning sessions at #TCT2024

1. Main Arena Session 1: – Live Case 1 - Leipzig Heart Center, Leipzig, Germany
   Monday, October 28: 7:30 AM - 8:30 AM EDT
   Room: Walter E. Washington Convention Center, Level 3, Main Arena, Ballroom
2. Management of "Young" Patients with Aortic Stenosis: A Lifelong Journey
   Wednesday, October 30: 8:40 AM - 9:40 AM EDT
   Room: Walter E. Washington Convention Center, Level 2, Education & Training Hall (Halls D-E), Structural Spotlight Room

See you there!